Synthesis and application of alpha-piperazinyl-containing phenylacetamide derivative

By developing phenylacetamide derivatives containing α-piperazinyl, the drug resistance and pollution problems of existing pesticides in preventing and treating plant fungal diseases and controlling fungal diseases after picking fruits, and the drupe brown rot bacteria have been achieved. Effective inhibition and fruit protection effects provide a scientific basis for new pesticides.

CN118878480AActive Publication Date: 2024-11-01GUIZHOU UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202410816198.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-24
Publication Date
2024-11-01
Estimated Expiration
2044-06-24

AI Technical Summary

Technical Problem

Existing pesticides have drug resistance and pollution problems in preventing and controlling plant fungal diseases and post-picking fruits to prevent and control fungal diseases, and lack agricultural chemicals with new structure, super-active, high selectivity and environmentally friendly properties.

Method used

A class of phenylacetamide derivatives containing α-piperazine groups were developed. By constructing a brand new active skeleton, the active 'piperazine' structure was introduced, and the structure of the compound was optimized to improve the antibacterial effect and procurement of drupetal brown rot bacteria. The protection effect of the fruit.

Benefits of technology

This compound shows good antibacterial effect, can effectively inhibit the spore germination of drupe brown rot bacteria, and provides good protection and control effects on fruits after picking. It has a novel structure and is suitable for the research and development of new pesticides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118878480A_ABST
    Figure CN118878480A_ABST
Patent Text Reader

Abstract

The invention discloses an alpha-piperazinyl-containing phenylacetamide derivative, which is characterized in that the structural formula of the alpha-piperazinyl-containing phenylacetamide derivative is as follows: # imgabs0 #, wherein R1 is hydrogen, trifluoromethyl, methoxyl or halogen, R2 is hydrogen, acetamido, methyl or halogen, and R3 is methyl or acetyl. A series of novel alpha-piperazinyl-containing phenylacetamide derivatives are designed and synthesized, and a biological activity test shows that the compounds not only have excellent bacteriostatic activity on monilinia sclerotiorum, but also can effectively inhibit germination of spores of the monilinia sclerotiorum; in addition, the fertilizer has good protection and prevention effects on brown rot of the picked pears.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of pharmaceutical chemistry, and in particular to a preparation method of a class of phenylacetamide derivatives containing alpha-piperazine groups and their application in preventing and controlling plant fungal diseases and preventing and controlling fungal diseases of fruits after picking. Background Art

[0002] In agricultural production, pesticides are an indispensable component. They have made great contributions to the development of agriculture and ensuring the increase of food production. There are many phenylacetamide compounds on the market that have been developed for pesticide production. For example, the herbicide dimethoate was launched in 1989. It is mainly used to control annual grass weeds or certain broad-leaved weeds. It is suitable for ornamental plants such as peanuts, peppers, tomatoes, cotton, soybeans, etc. In addition, Syngenta launched a new fungicide, α-hydroxylated phenylacetamide-mandipropamid in 2008. The main target is oomycete diseases. The fungicide can effectively prevent the germination of pathogenic bacteria spores, thereby inhibiting the growth of hyphae and spore formation. At the same time, it can quickly adsorb on the wax layer on the surface of plants, providing the most durable protective barrier for the control of fungal diseases. However, with the irregular use and abuse of a large number of pesticides, drug resistance and pollution problems have emerged. There is an urgent need to research and develop more agricultural chemicals with new structures, super activity, high selectivity and environmental protection performance to provide guarantees for the healthy and sustainable development of agricultural production.

[0003] As one of the key six-membered heterocyclic compounds, the piperazine ring is characterized by low toxicity, easy generation of multiple hydrogen bonds or ionic bonds, and the ability to regulate the lipid-water partition coefficient and constant pH value of the drug. It is considered to be a bridging molecule that can effectively connect highly efficient active groups to enhance biological activity, and its chemical properties can be optimized by introducing different groups. N-substituted piperazine compounds have been reported to have a wide range of pharmaceutical activities, such as antibacterial, anticancer and anti-tuberculosis activities. However, there are relatively few reports on piperazine compounds in pesticide development. Summary of the invention

[0004] The technical problem to be solved by the present invention is to provide a class of phenylacetamide derivatives containing α-piperazine groups, which are used for preventing and controlling plant fungal diseases and fungal diseases of fruits after picking.

[0005] The technical solution of the present invention is: a class of phenylacetamide derivatives containing α-piperazine, the structural formula of which is as follows: Wherein R1 is hydrogen, trifluoromethyl, methoxy or halogen, R2 is hydrogen, acetamido, methyl or halogen, and R3 is methyl or acetyl.

[0006] Preferably, the substitution position of R1 is single substitution at the ortho, meta or para position, and the substituent of the phenyl group of R2 is hydrogen, acetamide, methyl or halogen.

[0007] The R2 substituted phenyl group is a single or disubstituted group at the ortho, meta or para position.

[0008] A method for preparing a class of phenylacetamide derivatives containing α-piperazine, the reaction formula is as follows:

[0009]

[0010] The invention discloses a preparation method of a class of phenylacetamide derivatives containing α-piperazine and their application in preventing and controlling plant fungal diseases and preventing and controlling fungal diseases of fruits after picking.

[0011] Beneficial effects of the present invention: the present invention uses mandelic acid as a raw material to construct a new active skeleton, first constructs an amide structure with a substituted amino group, then introduces an active "piperazine" structure after halogenating the hydroxyl part of the mandelic acid, and finally designs and synthesizes a series of phenylacetamide derivatives containing α-piperazine, and searches for highly active compounds by adjusting the structures of three parts in the active skeleton (the benzene ring part based on mandelic acid, the compound containing formamide and the piperazine part). Compared with the traditional commercialized structure of amides, the present invention uses mandelic acid as a raw material to construct a new active structural skeleton of phenylacetamide containing α-piperazine, instead of synthesizing thioether compounds by introducing "oxadiazole" and "thiadiazole" structures; and compared with the commercialized structure starting from mandelic acid as a raw material, the present invention does not obtain a series of thioether compounds by replacing "hydrogen" atoms on the "hydroxyl", but replaces the "hydroxyl" structure in the mandelic acid structure by halogenation, introduces the active unit "piperazine" at this position, and discovers highly active compounds by exploring the influence of different structural units in the active skeleton on the activity. Through in vitro experiments on the compounds, it was found that this type of compound has a good antibacterial effect on stone fruit brown rot fungi; it can also effectively inhibit the germination of stone fruit brown rot fungi spores; in addition, it has a good protective and preventive effect on post-harvest pear brown rot. This type of compound has a novel structure and a wide range of uses, providing an important scientific basis for the research and development and creation of new pesticides. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 The effects of the compound and the commercial agent picoxystrobin on the germination and morphology of the spores of the stone fruit brown rot fungus (Monilinia fructicola);

[0013] Figure 2The compounds under different treatments and the commercial agent picoxystrobin had good protective and control effects on brown rot of post-harvest pears (2A, therapeutic effect; 2B, protective effect). DETAILED DESCRIPTION

[0014] Synthesis route of pyrazole acylhydrazone target compounds:

[0015]

[0016] Using amygdalone and substituted aniline as starting materials, the target compound Z was synthesized through condensation, halogenation and substitution.

[0017] Preparation of intermediates

[0018] Preparation of substituted phenyl-2-hydroxy-2-acetic acid aryl esters (B)

[0019]

[0020] A mixed solution of substituted mandelic acid (0.8 g), substituted aniline (0.5 g), dichloromethane (10 mL), and 4-dimethylaminopyridine (0.2 g) was reacted at room temperature for 2 h, and then 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.7 g) was added in an ice bath, and the reaction solvent was stirred for 6 hours, and the reaction was monitored by thin layer chromatography. After the solvent was dried by vacuum rotary drying, ethyl acetate and water were added for washing. The organic phase was retained, anhydrous sodium sulfate was added and dried overnight, and purified by silica gel column chromatography (dichloromethane / methanol = 5 / 1 to 3 / 1) to obtain intermediate product B, the physical and chemical data and spectral data are as follows:

[0021] N-(4-Acetamidophenyl)-2-hydroxy-2-phenylacetamide (B1): white solid, yield 72%, melting point 223–225°C. 1 HNMR(400MHz,DMSO-d6)δ9.87(s,1H,NH),9.85(s,1H,NH),7.61–7.59(m,2H,phenylH),7.52–7.47(m,4H,phenyl H),7.37–7.26(m,2H,phenyl H),7.31–7.27(m,1H,phenylH),6.40–6.39(d,J=4.0Hz,1H,OH),5.09–5.08(d,J=4.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3); 13C NMR (101MHz, DMSO-d6) δ170.79,167.95,140.90,135.07,133.71,128.04,127.54,126.54,120.04,119.18,73.92,23.87.

[0022]

[0023] N-(4-Acetamidophenyl)-2-hydroxy-2-(4-(trifluoromethyl)phenyl)acetamide (B2): white solid, yield 65%, melting point 227–229°C. 1 H NMR(500MHz,DMSO-d6)δ9.98(s,1H,NH),9.90(s,1H,NH),7.74(s,4H,phenyl H),7.61–7.57(m,2H,phenyl H),7.50–7.46(m,2H,phenyl H),6.68(s,1H,OH),5.22(s,1H,CH),2.01(s,3H,Ar-NHCOCH3).

[0024]

[0025] N-(4-acetamidophenyl)-2-(3-chlorophenyl)-2-hydroxyacetamide (B3): white solid, yield 70%, melting point 233–235°C. 1 H NMR(500MHz,DMSO-d6)δ9.92(s,1H,NH),9.89(s,1H,NH),7.59–7.56(m,3H,phenyl H),7.49–7.45(m,3H,phenyl H),7.40–7.34(m,2H,phenyl H),6.59–6.58(d,J=5.0Hz,1H,OH),5.12–5.11(d,J=5.0Hz,1H,CH),2.00(s,3H,Ar-NHCOCH3),

[0026]

[0027] N-(4-acetamidophenyl)-2-(3-fluorophenyl)-2-hydroxyacetamide (B4): white solid, yield 74%, melting point 221–223°C. 1H NMR(500MHz,DMSO-d6)δ9.87(s,1H,NH),9.86(s,1H,NH),7.59–7.57(m,2H,phenyl H),7.49–7.47(m,2H,phenyl H),7.42–7.34(m,3H,phenyl H),7.14–7.10(m,1H,phenyl H),6.55–6.54(d,J=5.0Hz,1H,OH),5.12–5.11(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3),

[0028]

[0029] N-(4-acetamidophenyl)-2-(4-bromophenyl)-2-hydroxyacetamide (B5): white solid, yield 74%, melting point 231–233°C. 1 H NMR(500MHz,DMSO-d6)δ9.90(s,1H,NH),9.89(s,1H,NH),7.59–7.54(m,4H,phenyl H),7.49–7.45(m,4H,phenyl H),6.54–6.53(d,J=5.0Hz,1H,OH),5.08–5.07(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3),

[0030]

[0031] N-(4-acetamidophenyl)-2-(4-fluorophenyl)-2-hydroxyacetamide (B6): white solid, yield 71%, melting point 226–228°C. 1 H NMR(500MHz,DMSO-d6)δ9.89(s,2H,NH-NH),7.61–7.45(m,6H,phenyl H),7.20–7.16(m,2H,phenyl H),6.48–6.47(d,J=5.0Hz,1H,OH),5.10–5.07(d,J=10.0Hz,1H,CH),2.00(s,3H,Ar-NHCOCH3),

[0032]

[0033] N-(4-acetamidophenyl)-2-(4-chlorophenyl)-2-hydroxyacetamide (B7): white solid, yield 66%, melting point 224–226°C. 1H NMR(500MHz,DMSO-d6)δ9.89(s,2H,NH-NH),7.61–7.45(m,6H,phenyl H),7.20–7.16(m,2H,phenyl H),6.48–6.47(d,J=5.0Hz,1H,OH),5.10–5.07(d,J=10.0Hz,1H,CH),2.00(s,3H,Ar-NHCOCH3).

[0034]

[0035] N-(4-acetamidophenyl)-2-(4-methoxyphenyl)-2-hydroxyacetamide (B8): white solid, yield 75%, melting point 223–225°C. 1 H NMR(500MHz,DMSO-d6)δ9.90(s,1H,NH),9.83(s,1H,NH),7.60–7.58(m,2H,phenyl H),7.49–7.47(m,2H,phenyl H),7.42–7.40(m,2H,phenyl H),6.92–6.89(m,2H,phenyl H),6.29(s,1H,OH),5.02(s,1H,CH),3.73(s,3H,OCH3),2.00(s,3H,Ar-NHCOCH3).

[0036]

[0037] N-(4-acetamidophenyl)-2-(2-chlorophenyl)-2-hydroxyacetamide (B9): white solid, yield 72%, melting point 221–223°C. 1 H NMR(500MHz,DMSO-d6)δ9.97(s,1H,NH),9.89(s,1H,NH),7.63–7.60(m,2H,phenyl H),7.57–7.55(m,1H,phenyl H),7.50–7.48(m,2H,phenyl H),7.45–7.43(m,1H,phenyl H),7.38–7.31(m,2H,phenyl H),6.64–6.62(d,J=10.0Hz,1H,OH),5.46–5.45(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3).

[0038]

[0039] 2-Hydroxy-N,2-diphenylacetamide (B10): white solid, yield 64%, melting point 193–195°C. 1 H NMR(500MHz,DMSO-d6)δ9.95(s,1H,NH),7.76–7.54(d,J=5.0Hz,2H,phenyl H),7.44–7.42(m,2H,phenyl H),7.38–7.(m,5H,phenyl H),7.20–7.16(m,1H,phenyl H),6.48(s,1H,OH),5.11(s,1H,CH),

[0040]

[0041] 2-Hydroxy-N-phenyl-2-(4-(trifluoromethyl)phenyl)acetamide (B11): white solid, yield 64%, melting point 191–193°C. 1 H NMR (500MHz, CDCl3) δ10.05(s,1H,NH),7.75–7.74(d,J=5.0Hz,4H,phenylH),7.70–7.68(m,2H,phenyl H),7.30–7.27(m,2H,phenyl H),7.07–7.04(m,1H,phenylH),6.71–6.70(d,J=5.0Hz,1H,OH),5.25–5.24(d,J=5.0Hz,1H,CH).

[0042]

[0043] 2-(3-Chlorophenyl)-2-hydroxy-N-phenylacetamide (B12): white solid, yield 60%, melting point 191–193°C. 1 H NMR(500MHz,CDCl3)δ9.98(s,1H,NH),7.70–7.67(m,2H,phenyl H),7.59–7.58(m,1H,phenyl H),7.49–7.47(m,1H,phenyl H),7.41–7.35(m,2H,phenyl H),7.31–7.27(m,2H,phenyl H),7.07–7.04(m,1H,phenyl H),6.62–6.61(d,J=5.0Hz,1H,OH),5.14–5.13(d,J=5.0Hz,1H,CH).

[0044]

[0045] 2-(3-Fluorophenyl)-2-hydroxy-N-phenylacetamide (B13): white solid, yield 65%, melting point 193–195°C. 1 H NMR(500MHz,CDCl3)δ8.19(s,1H,NH),7.53–7.51(m,2H,phenyl H),7.38–7.29(m,4H,phenyl H),7.23–7.21(m,1H,phenyl H),7.15–7.12(m,1H,phenyl H),7.07–7.03(m,1H,phenyl H),7.20–7.19(d,J=5.0Hz,1H,OH),3.50(s,1H,CH).

[0046]

[0047] 2-(4-Bromophenyl)-2-hydroxy-N-phenylacetamide (B14): white solid, yield 69%, melting point 196–198°C. 1 H NMR(500MHz,CDCl3)δ9.95(s,1H,NH),7.69–7.66(m,2H,phenyl H),7.57–7.54(m,2H,phenyl H),7.49–7.46(m,2H,phenyl H),7.30–7.26(m,2H,phenyl H),7.06–7.03(m,1H,phenyl H),6.57–6.56(d,J=5.0Hz,1H,OH),5.11–5.10(d,J=5.0Hz,1H,CH),

[0048]

[0049] 2-(4-Fluorophenyl)-2-hydroxy-N-phenylacetamide (B15): white solid, yield 65%, melting point 196–198°C. 1 H NMR(500MHz,DMSO-d6)δ10.08(s,1H,NH),7.71–7.67(m,2H,phenyl H),7.56–7.53(m,2H,phenyl H),7.43–7.41(m,2H,phenyl H),7.31–7.26(m,2H,phenyl H),7.06–7.03(m,1H,phenyl H),6.64(s,1H,OH),5.15(s,1H,CH).

[0050]

[0051] 2-(4-Chlorophenyl)-2-hydroxy-N-phenylacetamide (B16): white solid, yield 67%, melting point 197–199°C. 1 H NMR(500MHz,DMSO-d6)δ9.96(s,1H,NH),7.70–7.67(m,2H,phenyl H),7.57–7.55(m,2H,phenyl H),7.49–7.47(m,2H,phenyl H),7.30–7.27(m,2H,phenyl H),7.07–7.03(m,1H,phenyl H),6.57–6.56(d,J=5.0Hz,1H,OH),5.11–5.10(d,J=5.0Hz,1H,CH).

[0052]

[0053] 2-Hydroxy-2-(4-methoxyphenyl)-N-phenylacetamide (B17): white solid, yield 65%, melting point 192–194°C. 1 HNMR(500MHz,CDCl3)δ9.68(s,1H,NH),7.58–7.55(m,2H,phenyl H),7.34–7.29(m,4H,phenyl H),7.09–7.06(m,1H,phenyl H),6.84–6.85(m,2H,phenyl H),5.63–5.62(d,J=5.0Hz,1H,OH),5.10–5.48(m,1H,CH),3.77(s,3H,Ar-OCH3).

[0054]

[0055] 2-(2-Chlorophenyl)-2-hydroxy-N-phenylacetamide (B18): white solid, yield 71%, melting point 194–196°C. 1 H NMR(500MHz,DMSO-d6)δ10.09(s,1H,NH),7.73–7.70(m,2H,phenyl H),7.58–7.56(m,2H,phenyl H),7.45–7.43(m,1H,phenyl H),7.36–7.33(m,2H,phenyl H),7.32–7.29(m,2H,phenyl H),7.08–7.05(m,1H,phenyl H),6.77(s,1H,OH),5.48(s,1H,CH).

[0056]

[0057] N,2-bis(4-bromophenyl)-2-hydroxyphenylacetamide (B19): white solid, yield 74%, melting point 204–206°C. 1 H NMR(500MHz,DMSO-d6)δ10.29(s,1H,NH),7.70–7.66(m,2H,phenyl H),7.57–7.54(m,2H,phenyl H),7.49–7.45(m,4H,phenyl H),6.61–6.60(d,J=5.0Hz,1H,OH),5.11–5.10(d,J=5.0Hz,1H,CH).

[0058]

[0059] 2-(4-Bromophenyl)-N-(4-chloro-2-methylphenyl)-2-hydroxyacetamide (B20): white solid, yield 77%, melting point 200–202°C. 1 H NMR(500MHz, CDCl3)δ9.38(s,1H,NH),7.73–7.71(d,J=5.0Hz,1H,phenylH),7.59–7.57(m,2H,phenyl H),7.37–7.35(m,2H,phenyl H),7.18–7.16(m,2H,phenylH),5.48–5.46(m,1H,OH),5.25–5.24(d,J=10.0Hz,1H,CH),2.25(s,3H,Ar-CH3).

[0060]

[0061] 2-(4-bromophenyl)-N-(2,4-difluorophenyl)-2-hydroxyacetamide (B21): white solid, yield 74%, melting point 206-208°C. 1 H NMR(500MHz,CDCl3)δ9.60(s,1H,NH),8.04–8.00(m,1H,phenyl H),7.59–7.57(m,2H,phenyl H),7.35–7.33(m,2H,phenyl H),7.05–7.01(m,1H,phenyl H),6.96–6.92(m,1H,phenyl H),5.49–5.47(m,1H,OH),5.29–5.27(d,J=10.0Hz,1H,CH).

[0062]

[0063] 2-(4-bromophenyl)-N-(4-fluorophenyl)-2-hydroxyacetamide (B22): white solid, yield 74%, melting point 201–203°C. 1 HNMR(500MHz,CDCl3)δ8.58(s,1H,NH),8.27–8.22(m,1H,phenyl H),7.54–7.49(m,2H,phenyl H),7.39–7.36(m,2H,phenyl H),7.14–7.04(m,3H,phenyl H),5.19(s,1H,OH),3.56(s,1H,CH).

[0064]

[0065] 2-(4-Bromophenyl)-N-(3-fluorophenyl)-2-hydroxyacetamide (B23): white solid, yield 68%, melting point 207–209°C. 1 H NMR(500MHz,CDCl3)δ10.18(s,1H,NH),7.68–7.64(m,1H,phenyl H),7.58–7.55(m,2H,phenyl H),7.52–7.49(m,1H,phenyl H),7.47–7.45(m,2H,phenyl H),7.35–7.19(m,1H,phenyl H),6.91–6.86(m,1H,phenyl H),6.64–6.62(d,J=10.0Hz,1H,OH),5.12–5.11(d,J=5.0Hz,1H,CH).

[0066] Preparation of substituted phenyl-2-chloro-2-acetic acid aryl esters (C)

[0067]

[0068] At room temperature, N,N-dimethylformamide (0.5mL) and cyanuric chloride (TCT, 0.3g) were fully reacted, and then dichloromethane (20mL) and substituted phenyl-2-hydroxy-2-acetic acid aryl ester (1g) were added. After 3 hours of reaction at room temperature, the reaction was detected by thin layer chromatography. Subsequently, ammonium chloride (NH4Cl) solution was added for 5-6 extractions, the organic phase was retained, and anhydrous sodium sulfate was used for drying. Finally, it was purified by silica gel column chromatography (eluent: petroleum ether / ethyl acetate = 5 / 1 to 2 / 1) to obtain intermediate product C, and the physicochemical data and spectral data are as follows:

[0069]

[0070] N-(4-Acetamidophenyl)-2-chloro-2-phenylacetamide (C1): white solid, yield 47%, melting point 207–209°C. 1 H NMR(500MHz,DMSO-d6)δ10.47(s,1H,NH),9.95(s,1H,NH),7.60–7.58(m,2H,phenylH),7.54–7.49(m,4H,phenyl H),7.44–7.38(m,3H,phenyl H),5.72(s,1H,CH),2.01(s,3H,Ar-NHCO CH3 ); 13 C NMR (101MHz, DMSO-d6) δ170.79,167.95,140.90,135.07,128.04,127.54,126.54,120.04,119.18,73.92,23.87.

[0071]

[0072] N-(4-Acetamidophenyl)-2-chloro-2-(4-(trifluoromethyl)phenyl)acetamide (C2): white solid, yield 45%, melting point 206–208°C. 1 H NMR(500MHz,DMSO-d6)δ10.56(s,1H,NH),9.94(s,1H,NH),7.81(s,4H,phenyl H),7.53–7.51(m,2H,phenyl H),7.50–7.47(m,2H,phenyl H),5.84(s,1H,CH),2.01(s,3H,Ar-NHCOCH3).

[0073]

[0074] N-(4-Acetamidophenyl)-2-chloro-2-(3-chlorophenyl)acetamide (C3): white solid, yield 41%, melting point 211–213°C. 1 H NMR(500MHz,DMSO-d6)δ10.52(s,1H,NH),9.95(s,1H,NH),7.65–7.64(m,1H,phenyl H),7.54–7.45(m,7H,phenyl H),5.74(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3),

[0075]

[0076] N-(4-Acetamidophenyl)-2-chloro-2-(3-fluorophenyl)acetamide (C4): white solid, yield 44%, melting point 205–207°C. 1 H NMR(500MHz,DMSO-d6)δ10.52(s,1H,NH),9.95(s,1H,NH),7.65–7.64(m,1H,phenyl H),7.54–7.45(m,7H,phenyl H),5.74–5.73(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3),

[0077] N-(4-Acetamidophenyl)-2-chloro-2-(4-bromophenyl)acetamide (C5): white solid, yield 44%. Melting point 213–215°C. 1 H NMR(500MHz,DMSO-d6)δ9.90(s,1H,NH),9.88(s,1H,NH),7.61–7.58(m,2H,phenyl H),7.50–7.47(m,2H,phenyl H),7.40–7.33(m,2H,phenyl H),7.30–7.26(m,2H,phenyl H),5.09–5.08(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3),

[0078]

[0079] N-(4-Acetamidophenyl)-2-chloro-2-(4-fluorophenyl)acetamide (C6): white solid, yield 71%, melting point 211–213°C. 1 H NMR(500MHz,DMSO-d6)δ10.47(s,1H,NH),9.94(s,1H,NH),7.65–7.62(m,2H,phenyl H),7.54–7.47(m,4H,phenyl H),7.28–7.24(m,2H,phenyl H),5.74(s,1H,CH),2.01(s,3H,Ar-NHCOCH3),

[0080]

[0081] N-(4-Acetamidophenyl)-2-chloro-2-(4-chlorophenyl)acetamide (C7): white solid, yield 46%, melting point 206–209°C. 1H NMR(500MHz,DMSO-d6)δ10.51(s,1H,NH),9.94(s,1H,NH),7.62–7.59(m,2H,phenyl H),7.53–7.50(m,2H,phenyl H),7.49–7.47(m,4H,phenyl H)5.75(s,1H,CH),2.01(s,3H,Ar-NHCOCH3).

[0082]

[0083] N-(4-Acetamidophenyl)-2-chloro-2-(4-methoxyphenyl)acetamide (C8): white solid, yield 41%, melting point 206–208°C. 1 H NMR(500MHz,CDCl3)δ9.81(s,1H,NH),9.70(s,1H,NH),7.59–7.53(m,2H,phenyl H),7.53–7.47(m,2H,phenyl H),7.38–7.31(m,2H,phenyl H),6.94–6.88(m,2H,phenyl H),5.58(t,J=5.0Hz,CH),3.79(s,3H,Ar-OCH3),2.08(s,3H,Ar-NHCOCH3).

[0084]

[0085] N-(4-Acetamidophenyl)-2-chloro-2-(2-chlorophenyl)acetamide (C9): white solid, yield 45%, melting point 206–208°C. 1 H NMR(500MHz,CDCl3)δ9.96(s,1H,NH),9.70(s,2H,NH),7.58–7.56(m,2H,phenyl H),7.52–7.47(m,4H,phenyl H),7.35–7.25(m,2H,phenyl H),6.64–6.62(d,J=10.0Hz,1H,OH),5.62–5.61(d,J=5.0Hz,1H,CH),2.01(s,3H,Ar-NHCOCH3).

[0086]

[0087] 2-Chloro-N,2-diphenylacetamide (C10): white solid, yield 64%, melting point 187–189°C. 1H NMR(500MHz,DMSO-d6)δ8.44(s,1H,NH),7.58-7.55(m,2H,phenyl H),7.51–7.49(m,2H,phenylH),7.42–7.40(m,3H,phenyl H),7.38–7.33(m,2H,phenyl H),7.19–7.15(m,1H,phenylH),5.50(s,1H,CH).

[0088]

[0089] 2-Chloro-N-phenyl-2-(4-(trifluoromethyl)phenyl)acetamide (C11): white solid, yield 44%, melting point 185–187°C. 1 H NMR(500MHz,CDCl3)δ8.51(s,1H,NH),7.67–7.62(m,4H,phenyl H),7.57–7.53(m,2H,phenyl H),7.39–7.33(m,2H,phenyl H),7.21–7.17(m,1H,phenyl H),5.53(d,J=5.0Hz,1H,CH).

[0090]

[0091] 2-Chloro-2-(3-chlorophenyl)-N-phenylacetamide (C12): white solid, yield 46%, melting point 185–187°C. 1 HNMR (500MHz, CDCl3) δ8.70 (s, 1H, NH), 7.51–7.44 (m, 3H, phenyl H), 7.36–7.28 (m, 5H, phenyl H), 7.16–7.13 (t, J = 5.0Hz, 1H, phenyl H), 5.42 (s, 1H, CH).

[0092]

[0093] 2-Chloro-2-(3-fluorophenyl)-N-phenylacetamide (C13): white solid, yield 46%, melting point 186–188°C. 1 HNMR(500MHz,CDCl3)δ8.51(s,1H,NH),7.66–7.62(m,4H,phenyl H),7.57–7.54(m,2H,phenyl H),7.38–7.34(m,2H,phenyl H),7.21–7.17(m,1H,phenyl H),5.53(s,1H,CH).

[0094]

[0095] 2-Chloro-2-(4-bromophenyl)-N-phenylacetamide (C14): white solid, yield 45%, melting point 188-190°C. 1 HNMR(500MHz,CDCl3)δ8.60(s,1H,NH),7.61–7.57(m,2H,phenyl H),7.39–7.36(m,2H,phenyl H),7.34–7.30(m,2H,phenyl H),7.13–7.09(m,1H,phenyl H),7.91–7.89(m,2H,phenyl H),4.79(d,J=5.0Hz,1H,CH).

[0096]

[0097] 2-Chloro-2-(4-fluorophenyl)-N-phenylacetamide (C15): white solid, yield 65%, melting point 187–189°C. 1 HNMR(500MHz,DMSO-d6)δ10.38(s,1H,NH),7.63–7.59(m,2H,phenyl H),7.56–7.54(m,2H,phenyl H),7.26–7.22(m,2H,phenyl H),7.11–7.07(m,2H,phenyl H),7.04–7.01(m,1H,phenyl H),5.68(s,1H,CH).

[0098]

[0099] 2-Chloro-2-(4-chlorophenyl)-N-phenylacetamide (C16): white solid, yield 45%, melting point 181–183°C. 1 HNMR(500MHz,DMSO-d6)δ10.38(s,1H,NH),7.58–7.53(m,4H,phenyl H),7.37–7.53(m,2H,phenyl H),7.26–7.23(m,2H,phenyl H),7.05–7.01(m,1H,phenyl H),5.66(s,1H,CH).

[0100]

[0101] 2-Chloro-2-(4-methoxyphenyl)-N-phenylacetamide (C17): white solid, yield 47%, melting point 181–183°C. 1H NMR(500MHz,CDCl3)δ9.78(s,1H,NH),7.59–7.56(m,2H,phenyl H),7.42–7.39(m,2H,phenyl H),7.36–7.32(m,2H,phenyl H),7.08–7.05(m,1H,phenyl H), 6.94–6.92 (m, 2H, phenyl H), 5.58–5.57 (t, J = 5.0Hz, 1H, CH), 3.80 (s, 3H, Ar-OCH3).

[0102]

[0103] 2-Chloro-2-(2-chlorophenyl)-N-phenylacetamide (C18): white solid, yield 47%, melting point 183–185°C. 1 HNMR(500MHz,DMSO-d6)δ10.76(s,1H,NH),7.79–7.76(m,1H,phenyl H),7.63–7.60(m,2H,phenyl H),7.54–7.52(m,1H,phenyl H),7.45–7.43(m,2H,phenyl H),7.36–7.32(m,2H,phenyl H),7.13–7.09(m,1H,phenyl H),6.11(s,1H,CH).

[0104]

[0105] N,2-bis(4-bromophenyl)-2-chlorobenzeneacetamide (C19): white solid, yield 74%, melting point 196–198°C. 1 HNMR(500MHz,CDCl3)δ8.41(s,1H,NH),7.55–7.52(m,2H,phenyl H),7.46–7.45(m,2H,phenyl H),7.37–7.35(m,4H,phenyl H),5.44(s,1H,CH).

[0106]

[0107] 2-(4-Bromophenyl)-2-chloro-N-(4-chloro-2-methylphenyl)acetamide (C20): white solid, yield 47%, melting point 196–198°C. 1H NMR(500MHz, CDCl3)δ9.29(s,1H,NH),7.73–7.71(d,J=5.0Hz,1H,phenylH),7.57–7.54(m,2H,phenyl H),7.33–7.31(m,2H,phenyl H),7.20–7.16(m,2H,phenylH),5.69(t,J=5.0Hz,1H,CH),2.28(s,3H,Ar-CH3).

[0108]

[0109] 2-(4-Bromophenyl)-2-chloro-N-(2,4-difluorophenyl)acetamide (C21): white solid, yield 74%, melting point 197–199°C. 1 H NMR (500MHz, CDCl3) δ8.59(s,1H,NH),8.26–8.16(m,2H,phenyl H),7.40–7.37(m,2H,phenyl H),7.15–7.11(m,3H,phenyl H),5.47(s,1H,CH).

[0110]

[0111] 2-(4-Bromophenyl)-2-chloro-N-(4-fluorophenyl)acetamide (C22): white solid, yield 74%, melting point 192–194°C. 1 HNMR(500MHz,CDCl3)δ8.70(s,1H,NH),8.27–8.22(m,1H,phenyl H),7.56–7.51(m,2H,phenyl H),7.40–7.38(m,2H,phenyl H),7.16–7.08(m,3H,phenyl H),5.47(s,1H,CH).

[0112]

[0113] 2-(4-Bromophenyl)-2-chloro-N-(3-fluorophenyl)acetamide (C23): white solid, yield 44%, melting point 194–196°C. 1HNMR(500MHz,CDCl3)δ9.68(s,1H,NH),7.61–7.53(m,3H,phenyl H),7.38–7.27(m,4H,phenyl H),6.89–6.81(m,1H,phenyl H),5.50–5.48(d,J=10.0Hz,1H,OH),5.35–5.33(d,J=10.0Hz,1H,CH).

[0114] Synthesis of target compound Z

[0115] (1) Taking the synthesis of target compound Z1 as an example

[0116]

[0117] Add an appropriate amount of N,N-dimethylformamide solvent to the flask containing intermediate E, and then add 1-acetylpiperazine and potassium carbonate reagent. Stir the solvent at room temperature for 3 hours, and monitor the reaction by thin layer chromatography. Add the reagent to ammonium chloride solvent and wash 4-5 times, then add anhydrous sodium sulfate to dry. Purify by silica gel column chromatography (dichloromethane / methanol = 5 / 1) to obtain the target compound Z1. White solid, yield 44%, melting point 226-228℃. 1 H NMR(500MHz,DMSO-d6)δ10.39(s,1H,NH),10.08(s,1H,NH),7.56–7.53(m,3H,phenyl H),7.51–7.49(m,3H,phenyl H),7.37–7.33(m,2H,phenyl H),7.31–7.27(m,1H,phenyl H),4.15(s,1H,CH),3.44(s,2H,piperazinyl CONCH2),3.38(s,2H,piperazinyl CONCH2),2.40–2.37(m,2H,piperazinylCHN CH2 ),2.33–2.31(m,2H,piperazinyl CHN CH2 ),2.00(s,3H,Ar-NHCO CH3 ),1.95(s,3H,piperazinyl-NCOCH3); 13C NMR(101MHz,DMSO-d6)δ168.36,167.81,167.75,136.82,134.88,133.63,128.37,1 28.03,127.58,119.56,118.81,73.71,50.71,50.18,23.61,20.88; HRMS(ESI):m / z calcd for C 22 H 26 N4O3[M+H] + 395.2077, found 395.2065.

[0118] The synthesis methods of other target compounds are similar to that of target compound Z1.

[0119] (2) Target compound structure and physicochemical data

[0120]

[0121] Z2, yellow solid, yield 43%, melting point 230–232°C. 1 H NMR (500MHz, DMSO-d6) δ10.58(s,1H,NH),10.06(s,1H,NH),7.75–7.74(d,J=5.0Hz,4H,phenyl H),7.56–7.54(d,J=10.0Hz,2H,phenyl H),7.51–7.49(d,J=10.0Hz,2H,phenyl H),4.34(s,1H,CH),2.88(s,2H,piperazinyl CONCH2),2.72(s,2H,piperazinyl CONCH2),2.43–2.38(m,2H,piperazinylCHN CH2 ),2.34-2.32(t,J=10.0Hz,2H,piperazinyl CHN CH2 ),2.00(s,3H,Ar-NHCO CH3 ),1.96(s,3H,piperazinyl-NCOCH3); 13 C NMR(101MHz,DMSO-d6)δ168.31,168.24,167.98,162.52,142.03,135.48,133.87, 129.60,120.13,119.31,73.44,51.04,50.52,45.71,35.97,30.94,24.04,21.28; 1919F NMR (471 MHz, DMSO-d6) δ 62.67 (s, 3F, CF3); HRMS (ESI): m / z calculated for C 23 H 25 F3N4O3 [M+H] + 463.1951, found 463.1937.

[0122]

[0123] Z3, yellow solid, yield 46%, melting point 223–225 °C. 1 1H NMR (500 MHz, DMSO-d6) δ 10.22 (s, 1H, NH), 9.93 (s, 1H, NH), 7.57–7.56 (m, 1H, phenyl H), 7.52–7.48 (m, 4H, phenyl H), 7.46–7.44 (m, 1H, phenyl H), 7.40–7.39 (m, 2H, phenyl H), 4.08 (s, 1H, CH), 3.46–3.44 (m, 4H, piperazinyl CONCH2CH2), 2.88 (s, 1H, piperazinyl CHN CH ), 2.72 (s, 1H, piperazinylCHN CH ), 2.33–2.31 (d, J = 10.0 Hz, 2H, piperazinyl CHN CH2 ), 2.00 (s, 3H, Ar-NHCO CH3 ), 1.96 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (126 MHz, DMSO-d6) δ 168.23–168.10 (m), 139.57, 135.47, 133.76, 133.18, 130.45, 128.27 (d, J = 27.5 Hz), 127.58, 120.20, 119.31, 73.73, 51.09, 50.61, 45.65, 40.83, 35.95, 30.91, 24.07, 21.31; HRMS (ESI): m / z calculated forC 22 H 25 ClN4O3 [M+H] + 429.1688, found 429.1674.

[0124]

[0125]

[0126] Z4, yellow solid, yield 45%, melting point 228–230°C. 1 H NMR(500MHz,DMSO-d6)δ10.17(s,1H,NH),9.92(s,1H,NH),7.50–7.49(d,J=5.0Hz,3H,phenyl 7H),7.43–7.39(m,1H,phenylH),7.35–7.31(m,3H,phenyl H),7.18–7.13(m,1H,phenyl H),4.07(s,1H,CH),3.47–3.44(m,4H,piperazinyl CONCH2CH2),2.41–2.38(m,2H,piperazinyl CHN CH2 ),2.34–2.32(m,2H,piperazinyl CHN CH2 ),2.00(s,3H,Ar-NHCO CH3 ),1.96(s,3H,piperazinyl-NCO CH3 ); 13 CNMR(101MHz,DMSO-d6)δ168.29,168.20,168.19,163.47,161.05,139.94,139.87,135.46,133.78,130.53,130.45 ,125.00,120.26,119.35,115.39,115.17,114.96,73.87,51.11,50.63,45.68,40.86,24.07,21.32; HRMS(ESI):m / z calcd for C 22 H 25 FN4O3 413.1983, found 413.1973.

[0127]

[0128] Z5, yellow solid, yield 51%, melting point 224–226°C. 11H NMR (500 MHz, DMSO-d6) δ 10.25 (s, 1H, NH), 9.96 (s, 1H, NH), 7.58–7.56 (m, 2H, phenyl H), 7.50–7.49 (m, 4H, phenyl H), 7.46–7.45 (m, 2H, phenyl H), 4.07 (s, 1H, CH), 2.88 (s, 1H, piperazinyl CONCH), 2.73 (s, 1H, piperazinyl CONCH), 2.54 (s, 6H, piperazinyl C3H6), 2.00 (s, 3H, Ar-NHCOCH3), 1.96 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (101 MHz, DMSO-d6) δ 168.61, 168.52 (d, J = 9.1 Hz), 162.82, 136.80, 135.71, 134.13, 131.76, 131.27, 121.63, 120.49, 119.64, 73.83, 51.35, 50.79, 45.99, 36.27, 31.24, 24.35, 23.45, 21.59; HRMS (ESI): m / z calcd for C 22 H 25 BrN4O3 [M+H] + 473.1182, found 473.1169.

[0129]

[0130] Z6, yellow solid, yield 48%, melting point 228–230 °C. 1 1H NMR (500 MHz, DMSO-d6) δ 10.12 (s, 1H, NH), 9.90 (s, 1H, NH), 7.54–7.49 (m, 6H, phenyl H), 7.22–7.18 (m, 2H, phenyl H), 5.76 (s, 1H, CH), 4.04 (s, 2H, piperazinyl CONCH2), 3.82 (s, 2H, piperazinyl CONCH2), 2.39–2.35 (m, 2H, piperazinyl CHN CH2 ), 2.32–2.30 (m, 2H, piperazinyl CHN CH2 ), 2.0 (s, 3H, Ar-NHCO CH3 ), 1.96 (s, 3H, piperazinyl-NCOCH3); 1313C NMR (101 MHz, DMSO-d6) δ 168.57, 168.22, 168.13, 163.09, 160.66, 135.29, 133.81, 133.16, 133.13, 130.71, 130.62, 120.09, 119.27, 115.36, 115.15, 73.38, 50.99, 50.48, 45.61, 23.97, 21.21. 19 19F NMR (376 MHz, DMSO-d6) δ -114.30–-114.38 (m, 1F, CF); HRMS (ESI): m / z calcd for C 22 H 25 FN4O3 [M+H] + 413.1983, found 413.1969.

[0131]

[0132] Z7, yellow solid, yield 48%, melting point 221–223 °C. 1 1H NMR (500 MHz, DMSO-d6) δ 10.54 (s, 1H, NH), 10.10 (s, 1H, NH), 7.56–7.54 (m, 4H, phenyl H), 7.51–7.50 (m, 2H, phenyl H), 7.43–7.41 (m, 2H, phenyl H), 4.24 (s, 1H, CH), 3.44 (s, 2H, piperazinyl CONCH2), 3.38 (s, 2H, piperazinyl CONCH2), 2.41–2.36 (m, 2H, piperazinyl CHN CH2) , 2.32–2.28 (m, 2H, piperazinyl CHN CH2 ), 2.01 (s, 3H, Ar-NHCO CH3 ), 1.95 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (101 MHz, DMSO-d6) δ 168.37, 168.24, 168.20, 136.35, 135.40, 134.00, 132.60, 130.62, 128.46, 120.01, 119.24, 73.06, 55.12, 51.03, 50.50, 45.69, 24.05, 21.31; HRMS (ESI): m / z calcd for C 22 H 25 ClN4O3 [M+H]+ 429.1687, found 429.1674.

[0133]

[0134] Z8, yellow solid, yield 43%, melting point 224–226°C. 1 H NMR(500MHz,DMSO-d6)δ10.03(s,1H,NH),9.89(s,1H,NH),7.52–7.50(m,2H,phenyl H),7.48–7.47(m,2H,phenyl H),7.41–7.40(d,J=5.0Hz,2H,phenyl H),6.93–6.91(d,J=10.0Hz,2H,phenyl H),3.93(s,1H,CH),3.73(s,3H,Ar-COCH3),3.43(s,2H,piperazinyl CONCH2),2.54(s,2H,piperazinylCONCH2),2.38–2.35(m,2H,piperazinyl CHN CH2 ),2.31–2.29(m,2H,piperazinyl CHN CH2 ),2.00(s,3H,Ar-NHCO CH3 ),1.96(s,3H,piperazinyl-NCOCH3); 13 C NMR (126MHz, DMSO-d6) δ169.02, 168.09 (d, J = 10.9Hz), 159.01, 135.16, 133.91, 129.85, 128. 76,120.01,119.21,113.81,73.81,55.10,51.06,50.55,45.59,23.96,21.21; HRMS(ESI):m / z calcd forC 23 H 28 N4O4[M+H] + 425.2183, found 425.2167.

[0135]

[0136] Z9, yellow solid, yield 43%, melting point 223–225°C. 11H NMR (500 MHz, DMSO-d6) δ 10.18 (s, 1H, NH), 9.91 (s, 1H, NH), 7.79–7.77 (m, 1H, phenyl H), 7.54–7.51 (m, 2H, phenyl H), 7.50–7.47 (m, 2H, phenyl H), 7.46–7.45 (m, 1H, phenyl H), 7.40–7.32 (m, 2H, phenyl H), 5.76 (s, 1H, CH), 3.47–3.40 (m, 6H, piperazinyl CONC3H6), 2.44–2.36 (m, 2H, piperazinyl CHN CH2 ), 2.01 (s, 3H, Ar-NHCO CH3 ), 1.96 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (126 MHz, DMSO-d6) δ 169.87–167.65 (m), 135.58, 134.83, 133.55, 132.16, 131.41–129.20 (m), 127.24, 120.62 (d, J=49.9 Hz), 70.24, 51.01 (d, J=57.8 Hz), 24.55, 21.41; HRMS (ESI): m / z calcd for C 22 H 26 ClN4O3 [M+H] + 429.1687, found 429.1673.

[0137]

[0138] Z10, yellow solid, yield 49%, melting point 211–213 °C. 1 1H NMR (500 MHz, DMSO-d6) δ 10.23 (s, 1H, NH), 9.99 (s, 1H, NH), 7.54–7.51 (m, 3H, phenyl H), 7.50–7.47 (m, 3H, phenyl H), 7.36–7.33 (m, 2H, phenyl H), 7.31–7.27 (m, 1H, phenyl H), 4.04 (s, 1H, CH), 2.88 (s, 2H, piperazinylCONCH2), 2.72 (s, 2H, piperazinyl CONCH2), 2.54–2.52 (m, 2H, piperazinyl CHN CH2 ), 2.47–2.44 (m, 2H, piperazinyl CHN CH2 ),2.29(s,3H,Ar-NHCO CH3 ),2.00(s,3H,piperazinyl-NCH3); 13 CNMR(126MHz,DMSO-d6)δ168.61(d,J=25.5Hz),168.41,136.57,135.43,134.01,132.74,130.63,128.58,11 9.80(d,J=90.8Hz),73.84,57.73,54.43,50.34,45.32,23.71(d,J=103.1Hz),19.44,13.77; HRMS(ESI):m / z calcd for C 21 H 26 N4O2[M+H] + 367.2128, found 367.2116.

[0139]

[0140] Z11, white solid, yield 49%, melting point 216–218°C. 1 H NMR(400MHz,DMSO-d6)δ10.26(s,1H,NH),9.97(s,1H,NH),7.71(s,4H,phenyl H),7.47–7.44(m,4H,phenyl H),4.06(s,1H,CH),2.34–2.12(m,8H,piperazinyl C4H8),2.12(s,3H,Ar-NHCO CH3 ),1.99(s,3H,piperazinyl-NCH3); 13 C NMR (126MHz, DMSO-d6) δ168.09(d,J=5.0Hz),142.29,135.39,133.75(d,J=45.36Hz),129.45,125.30,125.27,120.10,119.32 74.31,54.65,50.73,45.75,23.98; 19 FNMR(376MHz,DMSO-d6)δ-60.95(s,3F,CF3); HRMS(ESI):m / z calcd for C 22 H 25 F3N4O2[M+H] + 435.1988, found 435.2002.

[0141]

[0142] Z12, yellow solid, yield 46%, melting point 207–209°C. 1 H NMR(500MHz,DMSO-d6)δ10.19(s,1H,NH),9.96(s,1H,NH),7.52–7.51(m,3H,phenyl H),7.50–7.49(m,3H,phenyl H),7.42–7.40(m,2H,phenyl H),3.99(s,1H,CH),2.41–2.17(m,8H,piperazinyl C4H8),2.13(s,3H,Ar-NHCO CH3 )2.00(s,3H,piperazinyl-NCH3); 13 C NMR(126MHz,DMSO-d6)δ168.41(d,J=44.2Hz),136.64,135.38,133.94,132.62,13 0.54,128.50,120.10,119.35,74.14,54.70,50.80,45.81,24.08; HRMS(ESI):m / z calcd for C 21 H 26 ClN4O2[M+H] + 401.1738, found 401.1728.

[0143]

[0144] Z13, yellow solid, yield 48%, melting point 215–218°C. 1 H NMR(500MHz,DMSO-d6)δ10.48(s,1H,NH),10.12(s,1H,NH),7.57–7.54(m,2H,phenyl H),7.52–7.50(m,2H,phenyl H),7.38–7.34(m,3H,phenyl H),7.13–7.09(m,1H,phenyl H),4.15(s,1H,CH),2.44–2.29(m,8H,piperazinyl C4H8),2.15(s,3H,Ar-NHCO CH3 ),2.01(s,3H,piperazinyl-NCH3); 1313C NMR (126 MHz, DMSO-d6) δ 168.38 (d, J = 21.2 Hz), 140.69 (d, J = 7.2 Hz), 135.42, 134.06, 130.36 (d, J = 8.1 Hz), 124.93, 119.68 (d, J = 89.5 Hz), 73.99, 54.61, 50.63, 45.65, 24.07; HRMS (ESI): m / z calcd for C 21 H 25 O2N4F [M+H] + 385.2034, found 385.2020.

[0145]

[0146]

[0147] Z14, yellow solid, yield 43%, melting point 214–216 °C. 1 1H NMR (500 MHz, DMSO-d6) δ 10.12 (s, 1H, NH), 9.93 (s, 1H, NH), 7.52–7.50 (m, 3H, phenyl H), 7.49–7.47 (m, 3H, phenyl H), 7.34–7.33 (m, 1H, phenyl H), 7.30–7.27 (m, 1H, phenyl H), 3.97 (s, 1H, CH), 2.88 (s, 2H, piperazinyl CONCH2), 2.72 (s, 2H, piperazinyl CONCH2), 2.38 (s, 2H, piperazinyl CHN CH2 ), 2.19 (s, 2H, piperazinyl CHN CH2 ), 2.00 (s, 3H, Ar-NHCO CH3 ), 1.90 (s, 3H, piperazinyl-NCH3); 13 13C NMR (101 MHz, DMSO-d6) δ 169.08, 168.28, 137.66, 135.31, 134.13, 128.44, 127.97, 120.03, 119.37, 75.00, 56.23, 54.71, 50.88, 45.81, 24.06, 18.73; HRMS (ESI): m / z calcd for C 21 H 25 N4O2Br [M+H] + 445.1233, found 445.1216.

[0148]

[0149] Z15, yellow solid, yield 43%, melting point 216–218°C. 1 H NMR(500MHz,DMSO-d6)δ10.35(s,1H,NH),10.09(s,1H,NH),7.56–7.49(m,6H,phenyl H),7.17–7.13(m,2H,phenyl H),4.05(s,1H,CH),2.33(s,8H,piperazinyl C4H8),2.11(s,3H,Ar-NHCO CH3 ),2.01(s,1H,piperazinyl-NCH3); 13 C NMR(101MHz,DMSO-d6)δ168.95,168.34,163.10,160.67,135.30,134.06,133.83,133.8 0,130.68,130.60,120.00,119.36,115.31,115.10,73.88,54.66,50.74,45.75,24.02; 19 FNMR(376MHz,DMSO-d6)δ-114.49–-114.57(m,1F,CF).HRMS(ESI):m / z calcd for C 21 H 25 FN4O2[M+H] + 385.2034, found 385.2022.

[0150]

[0151] Z16, yellow solid, yield 53%, melting point 212–214°C. 1 H NMR(500MHz,DMSO-d6)δ10.21(s,1H,NH),10.08(s,1H,NH),7.54–7.48(m,4H,phenyl H),7.42–7.41(d,J=5.0Hz,2H,phenylH),6.90–6.88(m,2H,phenyl H),3.94(s,1H,CH),3.74–3.68(m,4H,piperazinyl COCH2),2.41–2.31(m,4H,piperazinyl CHN CH2) ,2.17(s,3H,Ar-NHCO CH3), 2.01 (s, 1H, piperazinyl-NCH3); 13 C NMR (126 MHz, DMSO-d6) δ 169.24, 168.09, 158.91, 135.13, 134.08, 129.59 (d, J = 45.0 Hz), 119.81, 119.16, 113.71, 74.05, 54.80 (d, J = 75.0 Hz), 50.56, 45.51, 23.95; HRMS (ESI): m / z calcd for C 21 H 25 ClN4O2 [M+H] + 400.1738, found 401.2805.

[0152]

[0153] Z17, yellow solid, yield 47%, melting point 213–215 °C. 1 H NMR (500 MHz, DMSO-d6) δ 9.44 (s, 1H, NH), 7.74 (s, 1H, NH), 7.51–7.48 (m, 2H, phenyl H), 7.46–7.44 (m, 2H, phenyl H), 7.42–7.40 (m, 1H, phenyl H), 7.33–7.31 (m, 1H, phenyl H), 7.24–7.23 (m, 2H, phenyl H), 4.84 (s, 1H, CH), 2.62–2.50 (m, 8H, piperazinyl C4H8), 2.29 (s, 3H, Ar-NHCO CH3 ), 2.08 (s, 3H, piperazinyl-NCH3); 13 C NMR (126 MHz, DMSO-d6) δ 169.07, 168.70, 135.78, 134.75, 133.69, 132.56, 130.73, 130.21, 129.63, 127.00, 120.85, 120.35, 70.11, 55.62, 45.96, 24.47; HRMS (ESI): m / z calcd for C 21 H 25 ClN4O2 [M+H] + 401.1738, found 401.1734.

[0154]

[0155] Z18, white solid, yield 72%, melting point 212–214°C. 1 H NMR(500MHz, CDCl3)δ9.01(s,1H,NH),7.64–7.62(d,J=10.0Hz,2H,phenyl H),7.56–7.54(d,J=10.0Hz,2H,phenyl H),7.49–7.47(d,J=10.0Hz,2H,phenyl H),7.36–7.32(t,J=10.0Hz,3H,phenyl H),7.16–7.12(m,1H,phenyl H),4.13(s,1H,CH),3.69–3.68(d,J=5.0Hz,2H,piperazinylCONCH2),3.55–3.53(t,J=10.0Hz,2H,piperazinyl CONCH2),2.53–2.48(m,4H,piperazinyl CHN CH2CH2 ),2.06(s,3H,piperazinyl-NCOCH3); 13 C NMR (101MHz, CDCl3) δ169.11,167.96,137.26,129.56,129.30,129.24,129.01,1 25.88,124.88,119.69,75.53,51.48,51.22,46.33,41.48,21.38; HRMS(ESI):m / z calcd for C 20 H 23 N3O2[M+H] + 338.1863, found 338.1849.

[0156]

[0157] Z19, white solid, yield 65%, melting point 216–218°C. 1 H NMR(500MHz,CDCl3)δ9.03(s,1H,NH),7.57–7.55(d,J=10.0Hz,2H,phenyl H),7.36–7.33(m,6H,phenyl H),7.14–7.10(t,J=10.0Hz,1H,phenyl H),4.00(s,1H,CH),3.66–3.63(m,2H,piperazinyl CONCH2),3.53–3.50(t,J=10.0Hz,2H,piperazinyl CONCH2),2.50–2.45(m,4H,piperazinyl CHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3); 13 C NMR (101 MHz, CDCl3) δ 169.09, 168.93, 137.51, 134.62, 129.20, 128.97, 128.79, 124.58, 119.64, 76.16, 51.59, 51.30, 46.39, 41.54, 21.39; 19 F NMR (376 MHz, CDCl3) δ –62.67 (s, 3F, CF3); HRMS (ESI): m / z calcd for C 21 H 22 F3N3O2 [M+H] + 406.1736, found 406.1722.

[0158]

[0159] Z20, yellow solid, yield: 50%, melting point 211–213 °C. 1 H NMR (500 MHz, CDCl3) δ 9.02 (s, 1H, NH), 7.56–7.54 (d, J = 10.0 Hz, 2H, phenyl H), 7.35–7.30 (m, 4H, phenyl H), 7.29–7.27 (m, 1H, phenyl H), 7.24–7.21 (m, 1H, phenyl H), 4.00 (s, 1H, CH), 3.69–3.65 (m, 2H, piperazinyl CON CH2 ), 3.53–3.50 (m, 2H, piperazinyl CON CH2 ), 2.50–2.45 (m, 4H, piperazinyl CHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3); 13 C NMR (101 MHz, CDCl3) δ 169.11, 168.18, 137.33, 136.43, 134.84, 132.11, 130.71, 130.20, 119.26, 119.10, 119.02, 127.33, 124.79, 119.72, 77.48, 75.49, 51.49, 51.23, 46.35, 41.50, 21.39; HRMS (ESI): m / z calcd for C 20 H 22 ClN3O2 [M+H] +372.1473, found 372.1460.

[0160]

[0161] Z21, yellow solid, yield 70%, melting point 214–216°C. 1 H NMR(500MHz,CDCl3)δ8.98(s,1H,NH),7.56–7.54(d,J=10.0Hz,2H,phenyl H),7.36–7.31(m,3H,phenyl H),7.15–7.11(m,2H,phenyl H),7.09–7.01(m,2H,phenyl H),4.02(s,1H,CH),3.70–3.66(m,2H,piperazinyl CONCH2),3.54–3.52(t,J=5.0Hz,2H,piperazinyl CONCH2),2.52–2.46(m,4H,piperazinyl CHN CH2CH2 ),2.07(s,3H,piperazinyl-NCOCH3); 13 C NMR (101MHz, CDCl3) δ169.12,168.26,164.18,161.73,137.34,136.90,130.58,130.49,129.26,124.90,1 24.87,124.78,119.69,116.00,115.97,115.78,115.76,75.59,75.58,51.53,51.26,46.36,41.51,21.39; 19 F NMR (376MHz, CDCl3) δ-111.84–-111.91 (m, 1F, CF); HRMS (ESI): m / z calcdfor C 20 H 22 N3O2F[M+H] + 356.1768, found 356.1763.

[0162]

[0163] Z22, yellow solid, yield 72%, melting point 212–214°C. 11H NMR (500 MHz, CDCl3) δ 8.97 (s, 1H, NH), 7.55–7.54 (d, J = 5.0 Hz, 2H, phenyl H), 7.51–7.49 (m, 2H, phenyl H), 7.35–7.32 (t, J = 10.0 Hz, 3H, phenyl H), 7.23–7.21 (m, 2H, phenyl H), 7.15–7.12 (t, J = 10.0 Hz, 1H, phenyl H), 4.01 (s, 1H, CH), 3.69–3.66 (m, 2H, piperazinyl CONCH2), 3.53–3.51 (t, J = 5.0 Hz, 2H, piperazinyl CONCH2), 2.50–2.46 (m, 4H, piperazinyl CHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (126 MHz, CDCl3) δ 169.11, 168.31, 137.36, 133.46, 132.15, 130.73, 129.29, 124.79, 122.95, 119.68, 75.43, 51.50, 51.24, 6.34, 41.53, 21.39; HRMS (ESI): m / z calcd for C 20 H 22 BrN3O2 [M + H] + 416.0968, found 416.0954.

[0164]

[0165] Z23, yellow solid, yield 50%, melting point 216–218 °C. 1 1H NMR (500 MHz, CDCl3) δ 9.02 (s, 1H, NH), 7.56–7.54 (m, 2H, phenyl H), 7.35–7.30 (m, 4H, phenyl H), 7.15–7.11 (m, 1H, phenylH), 7.07–7.03 (m, 2H, phenyl H), 4.02 (s, 1H, CH), 3.68–3.66 (m, 2H, piperazinyl CONCH2), 3.53–3.51 (t, J = 5.0 Hz, 2H, piperazinyl CONCH2), 2.49–2.45 (m, 4H, piperazinylCHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3);13 13C NMR (101 MHz, CDCl3) δ 169.08, 168.60, 161.62, 137.34, 130.76, 130.68, 129.24, 124.70, 119.60, 116.05, 115.84, 77.42, 75.22, 51.48, 51.19, 46.34, 41.49, 21.35; 19 19F NMR (376 MHz, CDCl3) δ -112.79–-112.86 (m, 1F, CF); HRMS (ESI): m / z: calcd for C 20 H 22 FN3O2 [M+H] + 356.1768, found 356.1760.

[0166]

[0167] Z24, yellow solid, yield 71%, melting point 212–214 °C. 1 1H NMR (500 MHz, CDCl3) δ 8.98 (s, 1H, NH), 7.56–7.54 (m, 2H, phenyl H), 7.36–7.32 (m, 4H, phenyl H), 7.30–7.27 (m, 2H, phenyl H), 7.15–7.11 (t, J = 5.0 Hz, 1H, phenyl H), 4.02 (s, 1H, CH), 3.70–3.66 (m, 2H, piperazinyl CONCH2), 3.54–3.51 (t, J = 5.0 Hz, 2H, piperazinyl CONCH2), 2.50–2.44 (m, 4H, piperazinyl CHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (101 MHz, CDCl3) δ 169.10, 168.39, 137.35, 134.76, 132.93, 130.41, 129.28, 129.18, 124.77, 119.66, 75.34, 51.49, 51.22, 46.37, 41.52, 21.40; HRMS (ESI): m / z calcd for C 20 H 22 ClN3O2 [M+H]+ 372.1473, found 372.1459.

[0168]

[0169] Z25, white solid, yield 68%, melting point 214–216°C. 1 H NMR (400MHz, CDCl3) δ9.04(s,1H),7.60–7.56(m,2H,phenyl H),7.37–7.33(m,2H,phenyl H),7.29–7.26(m,2H,phenyl H),7.16–7.11(m,1H,phenyl H),6.91–6.88(m,2H,phenyl H),3.97(s,1H,CH),3.80(s,3H,Ar-OCH3),3.69–3.66(m,2H,piperazinyl CONCH2),3.53(t,J=4.0Hz,2H,piperazinylCONCH2),2.51–2.46(m,4H,piperazinyl CHN CH2CH2 ),2.08(s,3H,piperazinyl-NCOCH3); 13 CNMR (101MHz, CDCl3) δ169.50,168.27,159.15,138.87,129.99,128.83,123.71, 119.68,113.93,73.91,55.21,51.15,50.64,45.71,40.90,21.32HRMS(ESI):m / z calcd forC 21 H 25 N3O3[M+H] + 368.1968, found 368.1961.

[0170]

[0171] Z26, yellow solid, yield 70%, melting point 213–215°C. 11H NMR (500 MHz, CDCl3) δ 9.21 (s, 1H, NH), 7.58–7.55 (m, 2H, phenyl H), 7.42–7.37 (m, 2H, phenyl H), 7.34–7.30 (m, 3H, phenyl H), 7.26–7.24 (m, 2H, phenyl H), 7.13–7.10 (m, 1H, phenyl H), 4.82 (s, 1H, CH), 3.71–3.59 (m, 2H, piperazinyl CONCH2), 3.51–3.49 (t, J = 5.0 Hz, 2H, piperazinyl CONCH2), 2.58–2.50 (m, 4H, piperazinyl CHN CH2CH2 ), 2.04 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (126 MHz, CDCl3) δ 169.04, 168.28, 137.45, 135.52, 132.20, 130.64, 130.03 (d, J = 52.5 Hz), 129.21, 127.17, 124.66, 119.59, 70.25, 51.17, 50.72, 46.58, 41.72, 21.35; HRMS (ESI): m / z calcd for C 20 H 22 ClN3O2 [M + H] + 372.1473, found 372.1469.

[0172]

[0173] Z27, white solid, yield 67%, melting point 216–218 °C. 1 1H NMR (500 MHz, CDCl3) δ 9.02 (s, 1H, NH), 7.50–7.49 (m, 2H, phenyl H), 7.44–7.43 (d, J = 5.0 Hz, 4H, phenyl H), 7.20–7.19 (m, 2H, phenyl H), 4.01 (s, 1H, CH), 3.68–3.63 (m, 2H, piperazinyl CONCH2), 3.53–3.51 (t, J = 5.0 Hz, 2H, piperazinyl CONCH2), 2.48–2.44 (m, 4H, piperazinyl CHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3); 13C NMR (126MHz, CDCl3) δ169.10,168.39,136.44,133.10,132.25(d,J=4.3Hz),132.21,130 .75,123.09,121.22,117.36,75.35,51.48,51.23,46.35,41.50,21.40; HRMS(ESI):m / z calcd for C 20 H 21 Br2N3O2[M+H] + 493.2219, found 494.0479.

[0174]

[0175] Z28, white solid, yield 65%, melting point 220–222°C. 1 H NMR(500MHz,CDCl3)δ8.95(s,1H,NH),7.52–7.49(m,3H,Phenyl H),7.22–7.20(m,2H,Phenyl H),7.05–7.01(m,2H,PhenylH),4.01(s,1H,CH),3.71–3.63(m,2H,piperazinyl CON CH2 ),3.55–3.49(m,2H,piperazinyl CON CH2 ),2.53–2.43(m,4H,piperazinyl CHN CH2CH2 ),2.06(s,3H,piperazinyl-NCOCH3),1.25(s,3H,Ar CH3 ); 13 C NMR (126MHz, CDCl3) δ169.12, 168.29, 160.54, 158.60, 133.28 (d, J = 17.3Hz), 132.18, 130.72, 123 .02,121.38(d,J=7.9Hz),115.96(d,J=22.5Hz),75.27,51.47,51.23,46.33,41.46,29.84,21.46.

[0176]

[0177] Z29, white solid, yield 64%, melting point 226–228°C. 11H NMR (500 MHz, CDCl3) δ 9.47 (s, 1H, NH), 8.26–8.23 (m, 1H, phenyl H), 7.51–7.48 (m, 2H, phenyl H), 7.21–7.19 (m, 2H, phenyl H), 7.13–7.09 (m, 2H, phenyl H), 4.08 (s, 1H, CH), 3.72–3.62 (m, 2H, piperazinyl CONCH2), 3.57–3.49 (m, 2H, piperazinyl CONCH2), 2.52–2.42 (m, 4H, piperazinyl CHN CH2CH2 ), 2.05 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (126 MHz, CDCl3) δ 169.02, 168.38, 153.60, 151.67, 132.90, 132.03, 130.79, 125.75 (d, J = 10.1 Hz), 124.73 (d, J = 8.0 Hz), 122.89, 121.47, 75.11, 51.26, 51.01, 46.27, 41.42, 21.28.

[0178]

[0179] Z30, white solid, yield 71%, melting point 216–218 °C. 1 1H NMR (500 MHz, CDCl3) δ 8.98 (s, 1H, NH), 7.52–7.49 (m, 4H, phenyl H), 7.22–7.20 (m, 2H, phenyl H), 7.05–7.01 (m, 2H, phenyl H), 4.01 (s, 1H, CH), 3.69–3.65 (m, 2H, piperazinyl CONCH2), 3.54–3.51 (m, 2H, piperazinyl CONCH2), 2.48–2.43 (m, 4H, piperazinyl CHN CH2CH2 ), 2.06 (s, 3H, piperazinyl-NCOCH3); 1313C NMR (126 MHz, CDCl3) δ 173.59, 169.10, 168.29, 160.52, 158.58, 133.24, 132.16, 130.71, 122.99, 121.37 (d, J = 7.9 Hz), 115.94 (d, J = 22.6 Hz), 75.26, 55.55, 46.32, 41.45, 21.45; HRMS (ESI): m / z calcd for C 20 H 21 BrFN3O2 [M+H] + 433.0869, found 434.1728.

[0180]

[0181] Z31, white solid, yield 54%, melting point 216–218 °C. 1 1H NMR (500 MHz, CDCl3) δ 9.07 (s, 1H, NH), 7.50–7.48 (m, 3H, phenyl H), 7.29–7.24 (m, 1H, phenyl H), 7.21–7.16 (m, 3H, phenyl H), 6.84–6.80 (m, 1H, Phenyl H), 4.01 (s, 1H, CH), 3.70–3.62 (m, 2H, piperazinyl CONCH2), 3.52–3.50 (t, J = 5.0 Hz, 2H, piperazinyl CONCH2), 2.51–2.41 (m, 4H, piperazinyl CHN CH2CH2 ), 2.05 (s, 3H, piperazinyl-NCOCH3); 13 13C NMR (126 MHz, CDCl3) δ 169.05, 168.39, 164.09, 162.14, 138.80 (d, J = 10.8 Hz), 133.00, 132.17, 130.94–130.07 (m), 123.06 114.82 (d, J = 2.7 Hz), 114.47 (d, J = 21.3 Hz), 107.18 (d, J = 26.3 Hz), 75.29, 46.29, 41.44, 21.35; 19 19F NMR (376 MHz, CDCl3) δ -110.83– -110.88 (m, 1F, CF); HRMS (ESI): m / z calcd for C 20 H 21 BrFN3O2 [M+H] +433.0869, found 434.1728.

[0182] Biological activity test methods for target compounds

[0183] Antifungal activity test

[0184] The mycelium growth rate method was used to test the target compounds for preliminary activity screening against stone fruit brown rot fungus (Monilinia fructicola) at a concentration of 50 mg / L.

[0185] EC 50 Determination of value

[0186] According to the preliminary screening data, the fungal inhibition rate of the target compound with better activity was further determined at concentrations of 50, 25, 12.5, 6.25, and 3.125 mg / L. The diameter of the hyphae was measured using the cross method, and the inhibition rate was calculated using the same inhibition rate calculation method as above. Finally, the toxicity regression equation y=a+bx, EC 50 The value (x represents the inverse value of the concentration, y represents the statistical probability value of the inhibition rate at the corresponding concentration) and the correlation coefficient (R 2 ).

[0187] Inhibition test on spore germination of stone fruit brown rot pathogen

[0188] In a sterile environment, the fungus cake of the drupe brown rot fungus was inoculated into a culture dish containing PDA medium with a sterile needle, and the culture dish was placed in an incubator for alternating light and dark for 7 days to induce the mycelium with conidia to produce conidia of drupe brown rot. After the conidia cover the entire culture dish, use a sterile syringe to place the mycelium with conidia into a 10mL centrifuge tube, and add 5mL of sterile water to the centrifuge tube. Then place the centrifuge tube on an oscillator and shake for 15 minutes to shake a large number of conidia into the water, and then filter the mycelium through gauze several times to obtain a pure spore suspension. Then, adjust the concentration of the spore suspension by centrifugation or dilution, and finally obtain a concentration of 1×10 5 Spores / mL suspension. On the clean bench, add 3mL PDB solution to a clean test tube, add the prepared target compound and positive control drug (1% DMSO as blank control) at different concentrations to the test tube. Place the centrifuge tube at 25℃ (180rpm) and incubate for 3-4h. Observe the number of brown rot spores germination of the control and different concentrations of drupes under a stereo microscope, calculate the spore germination rate, and perform three parallel tests.

[0189] Testing the control of brown rot on post-harvest pear fruit

[0190] Take 10 mg of compound Z 31and picoxystrobin compounds were added with 1 mL of DMSO to prepare the stock solution, and then different amounts of distilled water were added to obtain final concentrations of 100 and 200 mg / L of the solvent, respectively. Pears with uniform size, flawless skin, uniform color, and naturally ripe were selected, washed with sterile distilled water, dried naturally, and the surface was evenly sprayed with 75% alcohol solution.

[0191] Protective activity of compounds on fruits

[0192] After drying, spray the agent evenly on the surface of the pears until it drips. At the same time, the blank control group was sprayed with the same dose of sterile distilled water containing 1% DMSO. The sprayed pears were kept in an incubator for 24 hours. After 24 hours, a sterile puncher was used to form holes with a diameter of 5 mm and a depth of 1 to 2 mm on the surface of the pears. A 5 mm drupe core rot fungus cake was added into the hole with a sterile needle. The inoculated pears were placed in a constant temperature incubator at 25°C and 90% humidity for 5 days. The lesion diameter was measured by the cross method. The experiment was repeated 3 times for each group.

[0193] Control effect (%) = (control spot diameter - experimental spot diameter) / control spot diameter.

[0194] Therapeutic activity of compounds in fruits

[0195] The fungus cake was inoculated on the surface of the fruit in a clean bench, cultured at 25°C for 24 hours, and then sprayed with reagents and sterile distilled water containing 1% DMSO in the same way. Other experimental operations and the calculation method of control effect were the same as those of protection effect.

[0196] Antibacterial activity data of target compounds

[0197] According to the above experimental steps, the in vitro bioactivity of all target compounds against stone fruit brown rot pathogens was tested by growth rate assay, and the results are shown in Tables 1 and 2.

[0198] Table 1 Antibacterial test results of compounds Z1-Z31 against stone fruit brown rot fungi at a concentration of 50 mg / L a

[0199]

[0200]

[0201] “a” Each group of experiments was repeated three times.

[0202] Table 2 EC values ​​of some compounds against stone fruit brown rot pathogen 50 a

[0203] serial number <![CDATA[EC 50 (μg / mL)]]> Toxicity equation <![CDATA[R 2 ]]> <![CDATA[Z4]]> 49.4±6.9 y=1.2946x+2.8074 0.953 <![CDATA[Z5]]> 25.0±0.6 y=1.6804x+2.6499 0.912 <![CDATA[Z9]]> 90.0±13.6 y=0.9617x+3.1207 0.949 <![CDATA[Z 10 ]]> 117.2±5.4 y=1.1687x+2.5819 0.922 <![CDATA[Z 13 ]]> 53.0±6.6 y=1.4184x+2.5542 0.939 <![CDATA[Z 26 ]]> 44.1±2.6 y=1.406x+2.6877 0.925 <![CDATA[Z 14 ]]> 50.3±1.2 y=1.292x+2.8013 0.938 <![CDATA[Z 18 ]]> 76.5±7.5 y=1.3371x+2.4812 0.957 <![CDATA[Z 19 ]]> 42.4±1.0 y=1.4074x+2.7102 0.925 <![CDATA[Z 20 ]]> 43.3±2.4 y=1.4336x+2.6542 0.979 <![CDATA[Z 21 ]]> 18.0±0.8 y=1.3328x+3.3277 0.935 <![CDATA[Z 22 ]]> 12.5±0.6 y=1.6242x+3.2167 0.967 <![CDATA[Z 23 ]]> 41.2±2.4 y=1.9053x+1.9239 0.967 <![CDATA[Z 28 ]]> 22.0±0.4 y=1.4026x+3.1162 0.915 <![CDATA[Z 29 ]]> 16.2±0.6 y=1.4006x+3.3078 0.895 <![CDATA[Z 30 ]]> 18.8±2.2 y=1.3567x+3.2716 0.992 <![CDATA[Z 31 ]]> 11.8±0.2 y=1.5422x+3.3454 0.994

[0204] “a” Each group of experiments was repeated three times.

[0205] As can be seen from Table 1, in the preliminary in vitro antifungal test, these compounds had significant inhibitory effects on stone fruit brown rot fungi at a concentration of 50 mg / L. 21 , Z 22 , the activity can reach more than 90%, so the compounds were selected for further activity screening against stone fruit brown rot fungi. Secondly, the inhibition rate of some compounds against other strains reached up to 64.3%. When the diamide compound was replaced by a monoamide compound, the activity of the compound was improved accordingly, indicating that the optimization of the compound structure is effective. However, when the piperazine group was connected to an electron-donating group, as shown in Table 1, there was no obvious effect on the improvement of the activity of the compound, and the activity of most compounds was not very ideal. According to Z 22 EC 50 =12.5mg / L, in Z 22 Di- and mono-substitutions are carried out on the basis of the structure in the hope of obtaining compounds with higher activity. For mono- and di-substituted compounds Z 27 –Z 31 Preliminary screening of resistance to stone fruit brown rot pathogens, as shown in Table 1, at a concentration of 50 mg / L, Z 27 –Z 31 The inhibitory activity of the compounds was 62.1%-91.0%. This shows again that the structural optimization of the compounds is effective. Although some compounds have good inhibition rates at 50 mg / L, due to the low concentration, EC 50 The higher the value, the lower the inhibition rate. As shown in Table 2, Z 31 EC against stone fruit brown rot pathogen 50 The value is 11.8mg / L. 21 , Z 22 , Z 28 and Z 29 EC against stone fruit brown rot 50 The values ​​were 18.0, 12.5, 22.0 and 16.2 mg / L respectively.

[0206] Table 3 Different concentrations of compound Z 31 Information about the spores of stone fruit brown rot fungus a

[0207] CK <![CDATA[1×EC 50 ]]> <![CDATA[2×EC 50 ]]> <![CDATA[4×EC 50 ]]> Number of germinated spores 328 279 155 68 Total spore count 379 412 370 373 Spore germination rate 86.49% 67.66% 41.87% 18.11% Inhibition rate -- 21.69% 51.54% 79.06%

[0208] a The values ​​are the average of 3 replicates; “--” indicates no data.

[0209] Table 4 Related information on spores of drupe brown rot fungus treated with different concentrations of commercial drug picoxystrobin a

[0210] CK <![CDATA[1×EC 50 ]]> <![CDATA[2×EC 50 ]]> <![CDATA[4×EC 50 ]]> Number of germinated spores 328 216 81 57 Total spore count 379 434 302 424 Spore germination rate 86.49% 49.79% 26.85% 13.48% Inhibition rate -- 43.32% 68.92% 84.40%

[0211] a The values ​​are the average of 3 replicates; “--” indicates no data.

[0212] As shown in Table 3, different concentrations (1×EC 50 , 2×EC 50 and 4×EC 50 )Z 31 The germination rate of spores after 4 h treatment was significantly lower than that of the blank control group (86.5%). The germination rates of spores at different concentrations were 67.6%, 41.8% and 18.1%, respectively, which were higher than those of the positive control (49.7%, 26.9% and 13.5%) (Table 4). These results confirmed that Z 31 It has good in vitro antifungal effect.

[0213] Table 5 Compound Z 31 Protective and curative effects of pyraclostrobin and picoxystrobin on brown rot of post-harvest pear fruit f

[0214]

[0215] f Values ​​are the mean ± SD of three replicates; “--” indicates no data; abcde IBM SPSS Statistics 20 data processing software was used to perform significant difference analysis according to the Duncan test method. Different letters in the same column indicate statistically significant differences (p<0.05).

[0216] As shown in Table 5, the incidence and lesion diameter of the untreated control fruit were significantly higher than those of the Z 31 Processed pears. 31 The protective activity at 100 and 200 mg / L concentrations was 60.6% and 79.4%, respectively, while the therapeutic activity at 100 and 200 mg / L concentrations was 55.1% and 70.5%, respectively. 31 The therapeutic and protective activities against pears were slightly lower than those of picoxystrobin; however, the spore germination rate data showed that Z 31 At both low and high concentrations, it showed better inhibition than picoxystrobin. Systematic analysis found that compound Z 31 It showed strong comprehensive activity in in vitro and in vivo tests, especially in the prevention and control of diseases of fruits after picking, and this type of active compounds showed potential application value.

Claims

1. A class of phenylacetamide derivatives containing α-piperazine groups, characterized in that: Its structural formula is as follows: wherein R1 is hydrogen, trifluoromethyl, methoxy or halogen, R2 is hydrogen, acetamido, methyl or halogen, and R3 is methyl or acetyl.

2. The α-piperazinyl-containing phenylacetamide derivative according to claim 1, characterized in that: The substitution position of R1 is single substitution at the ortho, meta or para position, and the substituent of R2 is hydrogen, acetamido, methyl or halogen.

3. The α-piperazinyl-containing phenylacetamide derivative according to claim 2, characterized in that: The R2 substituted phenyl group is monosubstituted or disubstituted at the ortho, meta or para position.

4. A method for preparing a class of α-piperazinyl-containing phenylacetamide derivatives according to any one of claims 1 to 3, characterized in that: The reaction formula is as follows:

5. Use of the α-piperazinyl-containing phenylacetamide derivatives according to any one of claims 1 to 3 in preventing and controlling plant fungal diseases.

6. Use of the α-piperazinyl-containing phenylacetamide derivatives according to any one of claims 1 to 3 in the prevention and treatment of fungal diseases in post-harvest fruits.

Citation Information

Patent Citations

  • Cold Menthol Receptor Antagonists

    US20100048619A1